These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

380 related items for PubMed ID: 15640848

  • 21. [Study on the safety and immunogenicity of MF59-adjuvanted influenza subunit vaccine in Chinese elderly].
    Li RC, Fang HH, Li YP, Liu YP, Nong Y, Huang GB.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Jun; 29(6):548-51. PubMed ID: 19040034
    [Abstract] [Full Text] [Related]

  • 22. Vaccination against influenza in patients with rheumatoid arthritis: the effect of rituximab on the humoral response.
    Oren S, Mandelboim M, Braun-Moscovici Y, Paran D, Ablin J, Litinsky I, Comaneshter D, Levartovsky D, Mendelson E, Azar R, Wigler I, Balbir-Gurman A, Caspi D, Elkayam O.
    Ann Rheum Dis; 2008 Jul; 67(7):937-41. PubMed ID: 17981914
    [Abstract] [Full Text] [Related]

  • 23. Studies of the 1996-1997 inactivated influenza vaccine among children attending day care: immunologic response, protection against infection, and clinical effectiveness.
    Hurwitz ES, Haber M, Chang A, Shope T, Teo ST, Giesick JS, Ginsberg MM, Cox NJ.
    J Infect Dis; 2000 Oct; 182(4):1218-21. PubMed ID: 10979921
    [Abstract] [Full Text] [Related]

  • 24. Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine.
    Treanor JJ, Campbell JD, Zangwill KM, Rowe T, Wolff M.
    N Engl J Med; 2006 Mar 30; 354(13):1343-51. PubMed ID: 16571878
    [Abstract] [Full Text] [Related]

  • 25. Immunogenicity of inactivated 2009 H1N1 influenza vaccine in pediatric liver transplant recipients.
    Torii Y, Kimura H, Ochi N, Kaneko K, Ando H, Kiuchi T, Ito Y.
    Vaccine; 2011 Jun 06; 29(25):4187-9. PubMed ID: 21513762
    [Abstract] [Full Text] [Related]

  • 26. Safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (H5N1) vaccine in infants and children.
    Nolan T, Richmond PC, Formica NT, Höschler K, Skeljo MV, Stoney T, McVernon J, Hartel G, Sawlwin DC, Bennet J, Ryan D, Basser RL, Zambon MC.
    Vaccine; 2008 Nov 25; 26(50):6383-91. PubMed ID: 18801398
    [Abstract] [Full Text] [Related]

  • 27. [An immunogenicity and reactogenicity study of a purified, inactivated trivalent influenza vaccine for parenteral administration prepared for the 1996-1997 season].
    Lupulescu E, Ioniţă E, Botez D, Matepciuc M, Tabra ME, Tecu C, Alexandrescu V, Munţiu A.
    Bacteriol Virusol Parazitol Epidemiol; 1997 Nov 25; 42(1-2):110-2. PubMed ID: 9235136
    [No Abstract] [Full Text] [Related]

  • 28. Evaluation of the safety, reactogenicity and immunogenicity of FluBlok trivalent recombinant baculovirus-expressed hemagglutinin influenza vaccine administered intramuscularly to healthy children aged 6-59 months.
    King JC, Cox MM, Reisinger K, Hedrick J, Graham I, Patriarca P.
    Vaccine; 2009 Nov 05; 27(47):6589-94. PubMed ID: 19716456
    [Abstract] [Full Text] [Related]

  • 29. [Immunogenicity and safety of domestic slit influenza vaccine].
    Zhu XJ, Zhang ZL, Li H, Su X, Guo XH, Chen W, Kou M, Duan WP.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Jul 05; 25(7):644. PubMed ID: 15308057
    [No Abstract] [Full Text] [Related]

  • 30. Long-lasting immunogenicity of a virosomal vaccine in older children and young adults with type I diabetes mellitus.
    Zuccotti GV, Scaramuzza A, Riboni S, Mameli C, Pariani E, Tanzi E, Zanetti A, Radaelli G.
    Vaccine; 2009 Aug 27; 27(39):5357-62. PubMed ID: 19607951
    [Abstract] [Full Text] [Related]

  • 31. [Evaluation of seroconversion after vaccination against influenza during the epidemic season 1991-1992 in Poland].
    Brydak L, Rudnicka H.
    Przegl Epidemiol; 1993 Aug 27; 47(3):275-83. PubMed ID: 8234846
    [Abstract] [Full Text] [Related]

  • 32. Trivalent inactivated influenza vaccine in African adults infected with human immunodeficient virus: double blind, randomized clinical trial of efficacy, immunogenicity, and safety.
    Madhi SA, Maskew M, Koen A, Kuwanda L, Besselaar TG, Naidoo D, Cohen C, Valette M, Cutland CL, Sanne I.
    Clin Infect Dis; 2011 Jan 01; 52(1):128-37. PubMed ID: 21148531
    [Abstract] [Full Text] [Related]

  • 33. [Safety and immunological effect of domestic split influenza virus vaccine].
    Zhang PR, Zhu XP, Zhou LJ, Liu YQ, Fan Y, Chen G, Chen Z, Liu Y, Sun HY, Wu JL.
    Zhonghua Yu Fang Yi Xue Za Zhi; 2009 Jul 01; 43(7):615-8. PubMed ID: 19954075
    [Abstract] [Full Text] [Related]

  • 34. A TritonX-100-split virion influenza vaccine is safe and fulfills the committee for proprietary medicinal products (CPMP) recommendations for the European Community for Immunogenicity, in Children, Adults and the Elderly.
    Lina B, Fletcher MA, Valette M, Saliou P, Aymard M.
    Biologicals; 2000 Jun 01; 28(2):95-103. PubMed ID: 10885616
    [Abstract] [Full Text] [Related]

  • 35. Safety and immunogenicity of a Proteosome -trivalent inactivated influenza vaccine, given nasally to healthy adults.
    Langley JM, Halperin SA, McNeil S, Smith B, Jones T, Burt D, Mallett CP, Lowell GH, Fries L.
    Vaccine; 2006 Mar 06; 24(10):1601-8. PubMed ID: 16303215
    [Abstract] [Full Text] [Related]

  • 36. Serum and mucosal immunologic responses in children following the administration of a new inactivated intranasal anti-influenza vaccine.
    Greenbaum E, Furst A, Kiderman A, Stewart B, Levy R, Schlesinger M, Morag A, Zakay-Rones Z.
    J Med Virol; 2001 Sep 06; 65(1):178-84. PubMed ID: 11505461
    [Abstract] [Full Text] [Related]

  • 37. Serum antibody responses after intradermal vaccination against influenza.
    Belshe RB, Newman FK, Cannon J, Duane C, Treanor J, Van Hoecke C, Howe BJ, Dubin G.
    N Engl J Med; 2004 Nov 25; 351(22):2286-94. PubMed ID: 15525713
    [Abstract] [Full Text] [Related]

  • 38. Immunogenicity and tolerability of a virosome influenza vaccine compared to split influenza vaccine in patients with sickle cell anemia.
    Souza AR, Braga JA, de Paiva TM, Loggetto SR, Azevedo RS, Weckx LY.
    Vaccine; 2010 Jan 22; 28(4):1117-20. PubMed ID: 20116631
    [Abstract] [Full Text] [Related]

  • 39. Immunological persistence of a seasonal influenza vaccine in people more than 3 years old.
    Bai Y, Shi N, Lu Q, Yang L, Wang Z, Li L, Han H, Zheng D, Luo F, Zhang Z, Ai X.
    Hum Vaccin Immunother; 2015 Jan 22; 11(7):1648-53. PubMed ID: 26083828
    [Abstract] [Full Text] [Related]

  • 40. Immunogenicity of a monovalent, aluminum-adjuvanted influenza whole virus vaccine for pandemic use.
    Hehme N, Engelmann H, Kuenzel W, Neumeier E, Saenger R.
    Virus Res; 2004 Jul 22; 103(1-2):163-71. PubMed ID: 15163505
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.